-
NN103 Beat MG releases two videos to raise awareness for Myasthenia Gravis
The NN103 Beat MG study Principal Investigator announces the release of two videos to raise awareness about myasthenia gravis (MG) and to provide details about the clnical trial. The first is an overview of the disease. The second, an overview of the study. MG is a chronic autoimmune neurological disorder of neuromuscular transmission affecting approximately 75,000 individuals in…
-
2014 Clinical Trials Methodology Course presentation on NeuroNEXT
Chris Coffey and Laurie Gutmann presented at the 2014 NINDS-funded Clinical Trials Methodology Course.
-
NN101 SMA poster presented at Families of SMA annual meeting
View the poster presented at the 2013 Families of SMA Annual Meeting by the NN101 SMA team.
-
NeuroNEXT praised as “a burst of speed for neurological research”
The August 2013 issue of Annals of Neurology describes how NeuroNEXT can streamline neurological research.